OOIR: Observatory of International Research

Papers

(The TQCC of Transfusion Medicine is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Convalescent plasma therapy for the treatment of patients with COVID‐19: Assessment of methods available for antibody detection and their correlation with neutralising antibody levels	55
Effect of convalescent plasma as complementary treatment in patients with moderate COVID‐19 infection	16
Comparison of four methods to measure haemoglobin concentrations in whole blood donors (COMPARE): A diagnostic accuracy study	15
Behaviour based screening questions and potential donation loss using the “for the assessment of individualised risk” screening criteria: A Canadian perspective	14
Machine learning for predicting preoperative red blood cell demand	14
Trust and distrust: Identifying recruitment targets for ethnic minority blood donors	12
Practical approach to transfusion management of post‐partum haemorrhage	12
Evaluating the risk of transfusion and transplant‐transmitted monkeypox infections	12
Motivators of and barriers to becoming a COVID‐19 convalescent plasma donor: A survey study	11
Adherence to blood product transfusion guidelines—An observational study of the current transfusion practice in a medical intensive care unit	10
Systematic review and meta‐analysis of randomised controlled trials testing the safety and efficacy of convalescent plasma in the treatment of coronavirus disease 2019 (COVID‐19): Evidence‐	10
The Norwegian experience with nationwide implementation of fetal RHD genotyping and targeted routine antenatal anti‐D prophylaxis	9
A review of whole‐blood donors' willingness, motives, barriers and interventions related to donating another substance of human origin	9
Convalescent plasma and COVID‐19: Time for a second—second look?	9
E‐learning/online education in transfusion medicine: A cross‐sectional international survey	8
Prophylactic tranexamic acid use in non‐cardiac surgeries at high risk for transfusion	8
Development and validation of a nomogram to predict intraoperative blood transfusion for gastric cancer surgery	8
Risk of hepatitis‐E virus infections among blood donors in a regional blood transfusion centre in western India	8
Detection frequencies and viral load distribution of parvovirus B19 DNA in blood and plasma donations in England	7
Beyond COVID‐19 and lessons learned in the United States	7
Effect of the first year of COVID‐19 pandemic on the collection and use of blood components in Colombia monitored through the national haemovigilance system	7
Deterrents in recruitment of COVID‐19 convalescent plasma donors: Experience from a hospital‐based blood centre in India	7
Transfusion in critical care: Past, present and future	7
Effect of patient blood management system and feedback programme on appropriateness of transfusion: An experience of Asia's first Bloodless Medicine Center on a hospital basis	7
Extracorporeal photopheresis to attenuate decline in lung function due to refractory obstructive allograft dysfunction	7

Systematic review of prevalence and risk factors of transfusion transmissible infections among blood donors, and blood safety improvements in Southern Africa	7
Association between the length of storage of transfused leukoreduced red blood cell units and hospital‐acquired infections in critically ill children: A secondary analysis of the TRIPICU st	7
Alloimmunisation rate of patients on Daratumumab: A retrospective cohort study of patients in England	7
Mapping anticipated advantages and disadvantages of implementation of extensive donor genotyping: A focus group approach	6
Assessment the knowledge of blood transfusion in Iranian nurses of Tehran's hospitals	6
Transfusion therapy of neonatal and paediatric patients: They are not just little adults	6
Recovery of platelet‐rich red blood cells and acquisition of convalescent plasma with a novel gravity‐driven blood separation device	6
Monitoring iron stores in Icelandic blood donors from 1997 through 2019	5
Transfusion 2024: A 5‐year plan for clinical and laboratory transfusion in England	5
Impact of Covid‐19 epidemic on the activities of a blood centre, transfusion support for infected patients and clinical outcomes	5
Histo‐blood group A is a risk factor for severe COVID‐19	5
Salvage of refractory post‐transfusion hyperhaemolysis by targeting hyperinflammation and macrophage activation with tocilizumab	5
Sickle cell disease patients in two London trusts: Genotyping including RH variants	5
Role of ABO blood system in COVID‐19: Findings from a southern Italian study	5
Extended red blood cell matching for all transfusion recipients is feasible	5
Comparative analysis of hepatitis B virus infections in blood donors born before and after the implementation of universal HBV vaccination in southern China	5
Importation of plasma and use of apheresis platelets as risk reduction measures for variant Creutzfeldt‐Jakob disease: The SaBTO review	5
Probable cefepime‐induced immune mediated hemolytic anaemia	4
Convalescent plasma for COVID‐19: Donor demographic factors associated high neutralising antibody titres	4
Pain control and functional improvement in patients treated by autologous conditioned serum after failure of platelet rich plasma treatments in knee osteoarthritis	4
Red blood cell transfusion in myelodysplastic syndromes: A systematic review	4
Passenger lymphocyte syndrome with severe haemolysis misdiagnosed/treated as cold agglutinin syndrome: Analysis of case and diagnostic error	4
Quantitative increases of extracellular vesicles in prolonged cold storage of platelets increases the potential to enhance fibrin clot formation	4
Hepatitis C virus screening reactive among blood donors in mainland China: A systematic review and meta‐analysis	4
Improving blood‐prescribing decisions: Evaluating the efficacy of a blood guidelines app	4
Screening of at‐risk blood donors for Chagas disease in non‐endemic countries: Lessons from a 2‐year experience in Tuscany, Italy	4
Utility of pre‐operative haemoglobin concentration to guide peri‐operative blood tests for hip and knee arthroplasty: A decision curve analysis	4
ABO‐incompatible convalescent plasma transfusion: Yes, you can	4
Kinetics of anti‐SARS‐COV2 spike protein IgG and IgA antibodies at 4°C: Implications for convalescent plasma stability	3
Plasma pooling in combination with amotosalen/UVA pathogen inactivation to increase standardisation and safety of therapeutic plasma units	3
The lack of anti‐PF4 antibodies in convalescent plasma from COVID‐19 infected blood donor	3
Prevalence and incidence of transfusion‐transmissible infections among blood donors in Malawi: A population‐level study	3
Patterns of paediatric massive blood transfusion protocol use in trauma and non‐trauma patients	3
London 2017: Lessons learned in transfusion emergency planning	3
The contribution and potential of older blood donors in Asia Pacific regions	3
The use of prothrombin complex concentrate in chronic liver disease: A review of the literature	3
Impact of the use of hydroxyethyl starch in granulocyte apheresis using Spectra Optia	3
Poster session	3
D‐‐phenotype due to RHD‐RHCE hybrid transcript in a case of severe haemolytic disease of newborn with anti‐Rh 17(Hrₒ) antibodies	3
Confirmed non‐invasive prenatal testing for foetal Rh blood group genotyping along with bi‐allelic short insertion/deletion polymorphisms as a positive internal control	3
Blood group P1 prediction using multiplex PCR genotyping of A4GALT among Thai blood donors	3
A physiology‐based trigger score to guide perioperative transfusion of allogeneic red blood cells: A multicentre randomised controlled trial	3
Paroxysmal cold hemoglobinuria: A diagnostic dilemma in a paediatric patient	3
Transfusion requirement prediction score for patients undergoing cardiac surgery: An experience from a tertiary care set‐up from South India	3
Prevalence of leucocyte antibodies in non‐transfused male and female platelet apheresis donors	3
Detection and analysis of blood donors seropositive for syphilis	3
The CRYOSTAT2 trial: The rationale and study protocol for a multi‐Centre, randomised, controlled trial evaluating the effects of early high‐dose cryoprecipitate in adult patients with major	3
Impact of microbial contamination of haematopoietic stem cells on post‐transplant outcomes: A retrospective study from tertiary care centre in India	3
An assessment of the management of anaemia in acute care settings in the United Kingdom: The value of a collaborative approach	2
A systematic review of the safety and efficacy of convalescent plasma or immunoglobulin treatment for people with severe respiratory viral infections due to coronaviruses or influenza	2

Randomised controlled trial of glucose‐6‐phosphate dehydrogenase deficient versus non‐deficient red blood cell transfusion in patients with hypoproliferative anaemia	2
Efficacy of octreotide in the treatment of gastrointestinal angiodysplasia in a patient with Glanzmann thrombasthenia	2
Using a scenario approach to assess for the current and future demand of immunoglobulins: An interview and literature study from The Netherlands	2
Anaphylactic reaction after pre‐deposit autologous blood transfusion	2
Splanchnic‐cerebral oxygenation ratio associated with packed red blood cell transfusion in preterm infants	2
Prevalence of anaemia in patients discharged from the paediatric intensive care unit	2
Individual and environmental determinants of serum ferritin levels: A structural equation model	2
Higher levels of von Willebrand factor in hospitalised patient plasma provides an explanation for the association of ABO blood group and secretor status with COVID19 severity	2
HLA‐DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization	2
Validation of an apoptosis assay for extracorporeal photopheresis	2
Effects of storage on quality and function of acid‐treated platelets with reduced HLA Class I surface expression	2
Effects of cryopreservation on gram‐positive bacteria contaminants in umbilical cord blood	2
A case of hyperhaemolysis syndrome in a pregnant Chinese woman with β‐thalassemia during perinatal transfusion	2
A prospective interventional study to assess the impact of a ‘structured compact training’ on knowledge and skills of safe blood transfusion practices among nurses working in a tertiary care institute	2
ABO(H) and Lewis blood group substances and disease treatment	2
Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti‐D in pregnancy	2
Serological screening and genetic analysis ofRhCEvariants in the Chinese Southern Han donors	2
Blood loss and transfusion risk in intramedullary nailing for subtrochanteric fractures	2
The ongoing dilemma of prophylactic platelet transfusions pre‐procedure and the development of evidence‐based recommendations	2
Re‐examine the transfusion transmitted risk of SARS‐CoV‐2 virus during a major COVID‐19 outbreak in 2022	2
BGvar: A comprehensive resource for blood group immunogenetics	2
Prevalence and specificity of red blood cell antibodies in patients transfused in tertiary hospitals in Burkina Faso	2
Role of donor self‐reporting in securing blood safety during COVID‐19 pandemic	2
Implementation of an anaemia walk‐in clinic: Feasibility and preliminary data from the Orthopedic University Hospital	2
A survey of nurses to assess transfusion practice at the bedside using an electronic identification system: Experience at a university hospital	2
Demographic, clinical, and biochemical predictors of pica in high‐intensity blood donors	2
Divergence in phenotyping and genotyping analysis of the Lewis histo‐blood group system	2
Motivations for blood donation by HIV‐positive individuals on antiretrovirals in South Africa: A qualitative study	2
Blood collection failures from a blood establishment perspective	2
High B‐cell activating factor levels in multi‐transfused thalassemia patients	2
Diagnostic accuracy of Abbott Architect Assay as a screening tool for human T‐cell leukaemia virus type‐1 and type‐2 infection in a London teaching hospital with a large solid organ transplant centre	2
Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience	2
Therapeutic apheresis and non‐blood donor related apheresis current practices at various blood centres of healthcare organisations of India: A brief online survey	2